FDA Inspection 1027726 — ImprimisRx NJ LLC
The FDA completed an inspection of ImprimisRx NJ LLC on Jul 10, 2017 in Ledgewood, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 10, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ledgewood, NJ (United States)